We are live on ! Find out more
XTNT icon

Xtant Medical Holdings
XTNT

16 hedge funds and large institutions have $61.9M invested in Xtant Medical Holdings in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

189% more capital inflows, than outflows

Capital inflows: $2.82M | Capital outflows: $978K

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

14% more funds holding

Funds holding: 14 → 16 (+2)

1.5% more ownership

Funds ownership: 83.26% → 84.77% (+1.5%)

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.36M
2
Bridgeway Capital Management
Bridgeway Capital Management
Texas
+$334K
3
BlackRock
BlackRock
New York
+$66.5K
4
UBS Group
UBS Group
Switzerland
+$30.8K
5
Renaissance Technologies
Renaissance Technologies
New York
+$22.7K

Top Sellers

Rank Fund Capital Flow
1
BC
Bruce & Co
Illinois
-$757K
2
Perkins Capital Management
Perkins Capital Management
Minnesota
-$218K
3
Morgan Stanley
Morgan Stanley
New York
-$2.98K

XTNT Hedge Fund Activity: Q2 2018 in Review

16 of the 4,386 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q2 2018, worth a combined $61.9M — down 28% from $85.4M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new XTNT positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.36M. The largest seller was Bruce & Co, cutting an estimated $757K.

  • 16 institutional investors held Xtant Medical Holdings (XTNT) as of Q2 2018, up from 14 in Q1 2018.
  • Funds reported $61.9M of Xtant Medical Holdings stock for Q2 2018, down 28% quarter-over-quarter.
  • 3 funds opened new Xtant Medical Holdings positions in Q2 2018 and 1 closed out, a net change of +2 holders.
  • The largest Xtant Medical Holdings buyer in Q2 2018 was Vanguard Group, an estimated $2.36M added.
  • The largest Xtant Medical Holdings seller in Q2 2018 was Bruce & Co, an estimated $757K sold.

Based on aggregated 13F filings for Q2 2018.